{
  "ptid_time": "009_S_4324_2016-02-11",
  "img_path": "/data/qiuhui/data/adni/images/009_S_4324/2016-02-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 83,182 mm³, 272.4% above the reference mean. With a Z-score of 6.82 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 4,570 mm³, 40.5% below the reference mean. With a Z-score of -4.55 (0.0th percentile), this represents profound atrophy; whole brain volume measures 781,939 mm³, 24.0% below the reference mean. With a Z-score of -2.99 (0.1th percentile), this represents significant atrophy; entorhinal cortex volume measures 1,804 mm³, 53.7% below the reference mean. With a Z-score of -4.16 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 11,587 mm³, 36.4% below the reference mean. With a Z-score of -4.10 (0.0th percentile), this represents profound atrophy; middle temporal gyrus volume measures 13,744 mm³, 33.0% below the reference mean. With a Z-score of -2.93 (0.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 66.8 years. Gender is Female. Education: 14 years. MMSE: 19.0. MoCA: 13.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.38 SUVR (significant elevated); Amyloid beta: 222.80 pg/mL (significant reduced); Total tau: 143.30 pg/mL (mild reduced); Phosphorylated tau: 13.68 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus) alongside significant whole-brain atrophy and ventricular enlargement. Combined with cognitive impairment (low MMSE/MoCA), amyloid positivity (elevated AV45), and APOE4 carrier status, this strongly suggests neurodegenerative disease consistent with Alzheimer's pathology.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease)  \n**Confidence:** **High**",
  "timestamp": "2025-07-25T22:18:29.364682"
}